Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarwyn Val. Regulatory News (MVI)

Share Price Information for Marwyn Val. (MVI)

Share Price is delayed by 15 minutes
Get Live Data
139.50    0.00 (0.00%)
Bid:
137.00
Ask:
142.00
Spread: 5.00 (3.65%)
Market Cap: £78.87m
MVI Live PriceLast checked at - London Stock Exchange

Intraday Marwyn Val. Share Chart

AdvancedAdvT Potential Merger

7 Jan 2022 14:48

RNS Number : 8234X
Marwyn Value Investors Limited
07 January 2022
 

 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA OR ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO

 

 

LEI: 213800L5751QTTVEA774

 

7 January 2022

 

 

Marwyn Value Investors Limited (the "Company" or "MVIL")

AdvancedAdvT Potential Merger

 

AdvancedAdvT Limited ("AdvT") has today announced that following its acquisition of 12,000,000 ordinary shares in M&C Saatchi Plc ("M&C"), representing c.9.82% of the issued share capital of M&C, it has confirmed that it is interested in exploring a share exchange merger between AdvT and M&C. There is no certainty that any formal offer for M&C will be forthcoming, nor as to the terms of any such formal offer.

 

AdvT's announcement can be viewed at https://www.londonstockexchange.com/news-article/ADVT/potential-merger/15278661 .

 

The Marwyn Funds1 collectively own 20,525,000 ordinary shares and 525,000 ordinary warrants in AdvT. As at 17 December 2021, being the latest available published Net Asset Value ("NAV") information for the Company, the investment in AdvT represents the following for each of the Company's issued share classes:

 

Share class

Look-through NAV value (£m)

% of NAV

Ordinary shares

16.35

16.8%

2016 Realisation shares

Nil

Nil

2021 Realisation shares

0.11

16.8%

 

1 comprises Marwyn Value Investors LP, Marwyn Value Investors II LP and MVI II Co-Invest LP

 

 

Company enquiries:

Company Secretary - Aztec Financial Services (Jersey) Limited

Katrina Boult / Jenny Keen

Telephone: 01534 833000

 

Investor Relations

Kam Bansil

Telephone: 020 7039 1901

 

Corporate Broker - Liberum Capital Limited

Chris Clarke / Owen Matthews

Telephone: 0203 100 2200

 

Marwyn Value Investors Limited is a closed-ended investment company on the London Stock Exchange Specialist Fund Segment - a fully regulated market for professional, institutional and sophisticated investors. Current investments through its underlying funds include Zegona Communications plc, AdvancedAdvT Limited, Marwyn Acquisition Company plc, Marwyn Acquisition Company II Limited, Marwyn Acquisition Company III Limited, MAC Alpha Limited and the operating business of Le Chameau.

For further information see http://www.marwynvalue.com. Neither the content of the Company's website, nor at https://www.londonstockexchange.com/news-article/ADVT/potential-merger/15278661, nor the content on any website accessible from hyperlinks on its website or any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION

This announcement includes statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "expects", "believes", "estimates", "envisages", "plans", "anticipates", "targets", "aims", "continues", "expects", "intends", "hopes", "may", "will", "would", "could" or "should" or, in each case, their negative or other variations or comparable terminology. These forward-looking statements include matters that are not facts. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances. A number of factors could cause actual results and developments to differ materially from those expressed or implied by the forward-looking statements. Forward-looking statements contained in this announcement based on past trends or activities should not be taken as a representation that such trends or activities will continue in the future. Subject to any requirement under the Listing Rules, Prospectus Rules, the Disclosure Guidance and Transparency Rules or other applicable legislation or regulation, the Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Investors should not place undue reliance on forward-looking statements, which speak only as of the date of this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEALFXELKAEFA
Date   Source Headline
2nd Jun 202610:10 amRNSNet Asset Value - 2021 Realisation Shares
2nd Jun 202610:05 amRNSNet Asset Value - 2016 Realisation Shares
2nd Jun 202610:00 amRNSNet Asset Value - Ordinary Shares
27th May 20265:03 pmRNSNotification of Major Interests in Shares
26th May 20264:43 pmRNSShare Acquisition
26th May 202611:00 amRNSNet Asset Values
18th May 202611:00 amRNSNet Asset Values
11th May 202611:00 amRNSNet Asset Values
5th May 202610:21 amRNSNet Asset Value - 2021 Realisation Shares
5th May 202610:05 amRNSNet Asset Value - 2016 Realisation Shares
5th May 202610:00 amRNSNet Asset Value - Ordinary Shares
30th Apr 20267:00 amRNSAnnual Financial Report
29th Apr 20267:00 amRNSInterim Dividend to Ordinary Shareholders
20th Apr 202611:00 amRNSNet Asset Values
16th Apr 202611:00 amRNSNet Asset Values
15th Apr 202610:10 amRNSNet Asset Value - 2021 Realisation Shares
15th Apr 202610:05 amRNSNet Asset Value - 2016 Realisation Shares
15th Apr 202610:00 amRNSNet Asset Value - Ordinary Shares
30th Mar 202611:00 amRNSNet Asset Values
26th Mar 20261:30 pmRNSShare Transfer
23rd Mar 202611:00 amRNSNet Asset Values
19th Mar 20262:00 pmRNSNotification of Major Interests in Shares
16th Mar 202611:00 amRNSNet Asset Values
9th Mar 202611:00 amRNSNet Asset Values
3rd Mar 202610:10 amRNSNet Asset Value - 2021 Realisation Shares
3rd Mar 202610:05 amRNSNet Asset Value - 2016 Realisation Shares
3rd Mar 202610:00 amRNSNet Asset Value - Ordinary Shares
23rd Feb 202611:00 amRNSNet Asset Values
16th Feb 202611:00 amRNSNet Asset Values
9th Feb 202611:00 amRNSNet Asset Values
3rd Feb 202610:10 amRNSNet Asset Value - 2021 Realisation Shares
3rd Feb 202610:05 amRNSNet Asset Value - 2016 Realisation Shares
3rd Feb 202610:00 amRNSNet Asset Value - Ordinary Shares
29th Jan 20267:00 amRNSInterim Dividend to Ordinary Shareholders
28th Jan 20266:29 pmRNSNotification of Major Interests in Shares
26th Jan 202611:00 amRNSNet Asset Values
19th Jan 202611:00 amRNSNet Asset Values
16th Jan 202611:00 amRNSNet Asset Values
15th Jan 202610:10 amRNSNet Asset Value - 2021 Realisation Shares
15th Jan 202610:05 amRNSNet Asset Value - 2016 Realisation Shares
15th Jan 202610:00 amRNSNet Asset Value - Ordinary Shares
8th Jan 202611:28 amRNSShare Transfer
6th Jan 202612:49 pmRNSNotification of Major Interests in Shares
23rd Dec 20252:00 pmRNSShare Dealings
23rd Dec 20252:00 pmRNSShare Dealings
22nd Dec 202511:00 amRNSNet Asset Values
18th Dec 20254:00 pmRNSShare Dealings
18th Dec 20254:00 pmRNSShare Dealings
15th Dec 202511:00 amRNSNet Asset Values
10th Dec 202512:14 pmRNSResult of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.